Home
>
National Drug Code (NDC)
>
Dextromethorphan Hydrobromide and Promethazine Hydrochloride
Dextromethorphan Hydrobromide and Promethazine Hydrochloride - 17856-0604-5 - (Dextromethorphan Hydrobromide and Promethazine Hydrochloride)
Drug Information of Dextromethorphan Hydrobromide and Promethazine Hydrochloride
| Product NDC: | 17856-0604 |
| Proprietary Name: | Dextromethorphan Hydrobromide and Promethazine Hydrochloride |
| Non Proprietary Name: | Dextromethorphan Hydrobromide and Promethazine Hydrochloride |
| Active Ingredient(s): | 15; 6.25 mg/5mL; mg/5mL & nbsp; Dextromethorphan Hydrobromide and Promethazine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SYRUP |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Dextromethorphan Hydrobromide and Promethazine Hydrochloride
| Product NDC: | 17856-0604 |
| Labeler Name: | Atlantic Biologicals Corps |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA088864 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19850104 |
Package Information of Dextromethorphan Hydrobromide and Promethazine Hydrochloride
| Package NDC: | 17856-0604-5 |
| Package Description: | 5 mL in 1 CUP (17856-0604-5) |
NDC Information of Dextromethorphan Hydrobromide and Promethazine Hydrochloride
| NDC Code | 17856-0604-5 |
| Proprietary Name | Dextromethorphan Hydrobromide and Promethazine Hydrochloride |
| Package Description | 5 mL in 1 CUP (17856-0604-5) |
| Product NDC | 17856-0604 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dextromethorphan Hydrobromide and Promethazine Hydrochloride |
| Dosage Form Name | SYRUP |
| Route Name | ORAL |
| Start Marketing Date | 19850104 |
| Marketing Category Name | ANDA |
| Labeler Name | Atlantic Biologicals Corps |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE |
| Strength Number | 15; 6.25 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes | Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],Sigma-1 Agonist [EPC],Uncompetitive NMDA Receptor Antagonists [MoA],Sigma-1 Receptor Agonists [MoA],Phenothiazine [EPC],Phenothiazines [Chemical/Ingredient] |
